科前生物：2025年前三季度净利润约3.38亿元

Company Performance - In Q3 2025, the company reported revenue of approximately 738 million yuan, representing a year-on-year increase of 10.87% [1] - The net profit attributable to shareholders was approximately 338 million yuan, showing a year-on-year increase of 29.62% [1] - Basic earnings per share reached 0.72 yuan, which is a year-on-year increase of 28.57% [1] Market Context - The company's market capitalization is currently 8.1 billion yuan [2] - The A-share market has surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology leading the market's new "slow bull" pattern [2]